1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pediatric Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Pediatric Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Allergy and Respiratory Drugs
1.4.3 Anti-Infectives
1.4.4 Cancer Therapies
1.4.5 Cardiovascular Drugs
1.4.6 Central Nervous System Drugs
1.4.7 Gastrointestinal Drugs
1.4.8 Hormone Drugs
1.4.9 Urological Drugs
1.5 Market by Application
1.5.1 Global Pediatric Drugs Market Share by Application: 2021-2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Drugstore
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Pediatric Drugs Market
1.8.1 Global Pediatric Drugs Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Pediatric Drugs Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Pediatric Drugs Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Pediatric Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Pediatric Drugs Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Pediatric Drugs Sales Volume Market Share by Region (2015-2020)
3.2 Global Pediatric Drugs Sales Revenue Market Share by Region (2015-2020)
3.3 North America Pediatric Drugs Sales Volume
3.3.1 North America Pediatric Drugs Sales Volume Growth Rate (2015-2020)
3.3.2 North America Pediatric Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Pediatric Drugs Sales Volume
3.4.1 East Asia Pediatric Drugs Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Pediatric Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Pediatric Drugs Sales Volume (2015-2020)
3.5.1 Europe Pediatric Drugs Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Pediatric Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Pediatric Drugs Sales Volume (2015-2020)
3.6.1 South Asia Pediatric Drugs Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Pediatric Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Pediatric Drugs Sales Volume (2015-2020)
3.7.1 Southeast Asia Pediatric Drugs Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Pediatric Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Pediatric Drugs Sales Volume (2015-2020)
3.8.1 Middle East Pediatric Drugs Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Pediatric Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Pediatric Drugs Sales Volume (2015-2020)
3.9.1 Africa Pediatric Drugs Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Pediatric Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Pediatric Drugs Sales Volume (2015-2020)
3.10.1 Oceania Pediatric Drugs Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Pediatric Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Pediatric Drugs Sales Volume (2015-2020)
3.11.1 South America Pediatric Drugs Sales Volume Growth Rate (2015-2020)
3.11.2 South America Pediatric Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Pediatric Drugs Sales Volume (2015-2020)
3.12.1 Rest of the World Pediatric Drugs Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Pediatric Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Pediatric Drugs Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Pediatric Drugs Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Pediatric Drugs Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Pediatric Drugs Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Pediatric Drugs Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Pediatric Drugs Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Pediatric Drugs Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Pediatric Drugs Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Pediatric Drugs Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Pediatric Drugs Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Pediatric Drugs Sales Volume Market Share by Type (2015-2020)
14.2 Global Pediatric Drugs Sales Revenue Market Share by Type (2015-2020)
14.3 Global Pediatric Drugs Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Pediatric Drugs Consumption Volume by Application (2015-2020)
15.2 Global Pediatric Drugs Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Pediatric Drugs Business
16.1 Abbott Laboratories
16.1.1 Abbott Laboratories Company Profile
16.1.2 Abbott Laboratories Pediatric Drugs Product Specification
16.1.3 Abbott Laboratories Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Genentech
16.2.1 Genentech Company Profile
16.2.2 Genentech Pediatric Drugs Product Specification
16.2.3 Genentech Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Bristol-Myers Squibb
16.3.1 Bristol-Myers Squibb Company Profile
16.3.2 Bristol-Myers Squibb Pediatric Drugs Product Specification
16.3.3 Bristol-Myers Squibb Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Bayer
16.4.1 Bayer Company Profile
16.4.2 Bayer Pediatric Drugs Product Specification
16.4.3 Bayer Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Forest Laboratories
16.5.1 Forest Laboratories Company Profile
16.5.2 Forest Laboratories Pediatric Drugs Product Specification
16.5.3 Forest Laboratories Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Boehringer Ingelheim
16.6.1 Boehringer Ingelheim Company Profile
16.6.2 Boehringer Ingelheim Pediatric Drugs Product Specification
16.6.3 Boehringer Ingelheim Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Johnson & Johnson
16.7.1 Johnson & Johnson Company Profile
16.7.2 Johnson & Johnson Pediatric Drugs Product Specification
16.7.3 Johnson & Johnson Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Eli Lilly
16.8.1 Eli Lilly Company Profile
16.8.2 Eli Lilly Pediatric Drugs Product Specification
16.8.3 Eli Lilly Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Colgate Oral Pharmaceuticals
16.9.1 Colgate Oral Pharmaceuticals Company Profile
16.9.2 Colgate Oral Pharmaceuticals Pediatric Drugs Product Specification
16.9.3 Colgate Oral Pharmaceuticals Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 GlaxoSmithKline
16.10.1 GlaxoSmithKline Company Profile
16.10.2 GlaxoSmithKline Pediatric Drugs Product Specification
16.10.3 GlaxoSmithKline Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Pfizer
16.11.1 Pfizer Company Profile
16.11.2 Pfizer Pediatric Drugs Product Specification
16.11.3 Pfizer Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Schering-Plough
16.12.1 Schering-Plough Company Profile
16.12.2 Schering-Plough Pediatric Drugs Product Specification
16.12.3 Schering-Plough Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 MedImmune
16.13.1 MedImmune Company Profile
16.13.2 MedImmune Pediatric Drugs Product Specification
16.13.3 MedImmune Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Pharmacia
16.14.1 Pharmacia Company Profile
16.14.2 Pharmacia Pediatric Drugs Product Specification
16.14.3 Pharmacia Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 Novo Nordisk
16.15.1 Novo Nordisk Company Profile
16.15.2 Novo Nordisk Pediatric Drugs Product Specification
16.15.3 Novo Nordisk Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 Merck
16.16.1 Merck Company Profile
16.16.2 Merck Pediatric Drugs Product Specification
16.16.3 Merck Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.17 Roche
16.17.1 Roche Company Profile
16.17.2 Roche Pediatric Drugs Product Specification
16.17.3 Roche Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.18 Novartis Pharmaceuticals
16.18.1 Novartis Pharmaceuticals Company Profile
16.18.2 Novartis Pharmaceuticals Pediatric Drugs Product Specification
16.18.3 Novartis Pharmaceuticals Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Pediatric Drugs Manufacturing Cost Analysis
17.1 Pediatric Drugs Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Pediatric Drugs
17.4 Pediatric Drugs Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Pediatric Drugs Distributors List
18.3 Pediatric Drugs Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Pediatric Drugs (2021-2026)
20.2 Global Forecasted Revenue of Pediatric Drugs (2021-2026)
20.3 Global Forecasted Price of Pediatric Drugs (2015-2026)
20.4 Global Forecasted Production of Pediatric Drugs by Region (2021-2026)
20.4.1 North America Pediatric Drugs Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Pediatric Drugs Production, Revenue Forecast (2021-2026)
20.4.3 Europe Pediatric Drugs Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Pediatric Drugs Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Pediatric Drugs Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Pediatric Drugs Production, Revenue Forecast (2021-2026)
20.4.7 Africa Pediatric Drugs Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Pediatric Drugs Production, Revenue Forecast (2021-2026)
20.4.9 South America Pediatric Drugs Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Pediatric Drugs Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Pediatric Drugs by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Pediatric Drugs by Country
21.2 East Asia Market Forecasted Consumption of Pediatric Drugs by Country
21.3 Europe Market Forecasted Consumption of Pediatric Drugs by Countriy
21.4 South Asia Forecasted Consumption of Pediatric Drugs by Country
21.5 Southeast Asia Forecasted Consumption of Pediatric Drugs by Country
21.6 Middle East Forecasted Consumption of Pediatric Drugs by Country
21.7 Africa Forecasted Consumption of Pediatric Drugs by Country
21.8 Oceania Forecasted Consumption of Pediatric Drugs by Country
21.9 South America Forecasted Consumption of Pediatric Drugs by Country
21.10 Rest of the world Forecasted Consumption of Pediatric Drugs by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer